Academisch Medisch Centrum — Clinical Trial Site

87 Registered trials

30 Currently recruiting

Organisation

Academisch Medisch Centrum

Location

Amsterdam, Netherlands

Identifier

ORG-100006320

Address

Meibergdreef 9, 1105 AZ, Netherlands

Departments

(Pediatric) Neurology
#1500:Dept. of Hematology
#1700: Heart center, department of cardiology
#3701: Cardiology
#NDL1 Pharmacy
2500: Hematology
3701: Cardiology
Academisch Medisch Centrum
AMC
Amsterdam UMC, Locatie AMC (#1)
Amsterdam Universitair Medische Centra(#1)
Cardiology
Child Neurology, Neurology and Paediatrics
Children's nephrology
Clinical Hematology Department
Department of Gastroenterology & Hepatology (MDL)
Department of Hematology
Department of Intensive Care Medicine
Department of Medical Oncology
Department of Neurolog
Department of Oncology
Department of Ophthalmology
Department of Pulmonology
Department of Vascular Medicine
Dermatology
Gastroenterology
Gastrointestinal tract
Gynaecology
Hematologie (AMC)
Hematology
Infectious Diseases
Internal and Vascular Medicine & Haemophilia
Internal Medicine / Dialysis
MDL
Medical Oncology
Medische Oncologie
metabole ziekten
N/A
NA
Nephrology
Neurology
Neurosurgery
Oncology
Paediatric Gastroenterology
Paediatrics
Parent
Pulmonary Science
Rheumatology
Rheumatology and Clinical Immunology
Surgery
Urology
Vascular medicine
Vascular Medicine Clin Trial Unit

Clinical trials at this site (87)

Search interface

A study to assess the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with active idiopathic inflammat… Recruiting

2022-502851-79-00 Active Idiopathic Inflammatory Myopathy (IIM) 5 2023-09-20
Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells Recruiting

2023-507041-28-00 Solid and Hematological Malignancies 4 2022-11-28
Effects of N-Acetyl-L-Leucine on Niemann-Pick disease type C (NPC): A Phase III, randomized, placebo-controlled, double-blind, crossover stu… Recruiting

2023-510278-14-00 Niemann-Pick disease type C 5 2022-06-16
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten (CK-3773274) in Adults With Hypertrophic Cardiomyo… Recruiting

2023-508963-58-00 Symptomatic hypertrophic cardiomyopathy (HCM) 4 2022-01-31
Safety, efficacy and pharmacokinetics of sparsentan in pediatric subjects with selected kidney diseases. Recruiting

2023-505497-14-00 Proteinuric glomerular diseases including: •Focal segm 4 2021-12-09
Study of two doses of crizanlizumab versus placebo in adolescent and adult sickle cell disease patients Recruiting

2023-508689-14-00 Sickle cell disease 5 2019-09-16
Prospective Randomized Open-label Trial to Evaluate risk faCTor management in patients with Unruptured intracranial aneurysms (PROTECT-U) Recruiting

2024-517236-22-00 Intradural saccular unruptured aneurysm 5 2017-09-20
CAR T-cell therapy long term follow-up Recruiting

2023-508128-37-00 All patients who have been treated with Novartis or Pen 5 2017-07-19
DRUP trial Recruiting

2023-509152-33-00 Advanced solid tumor 4 2016-07-25
A Study to Find Out How Safe and Effective AZD0780 Is for Adults with High 'Bad' Cholesterol from an Inherited Condition Ended

2025-520520-17-00 Heterozygous familial hypercholesterolaemia 5 2025-09-05
Long-term Follow-up Study of Male Adults with Hemophilia B Previously Treated with Etranacogene Dezaparvovec (CSL222) Ended

2023-503765-37-00 Hemophilia B 10 2024-09-30
A study to Evaluate the Efficacy and Safety of Mitapivat in Subjects With Transfusion-Dependent Alpha- or Beta-Thalassemia (ENERGIZE-T) Ended

2024-512747-23-00 Transfusion-Dependent Alpha- or Beta-Thalassemia 5 2024-07-30
A study evaluating the safety and efficacy of GLPG5101 (19CP02) in subjects with non-Hodgkin lymphoma Ended

2022-502661-23-00 Relapsed/refractory B-cell non-Hodgkin lymphoma 7 2024-06-11
A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants with Severe Hypertriglyceridemia (SHTG) Ended

2022-501999-26-00 Severe Hypertriglyceridemia (SHTG) 5 2023-07-12
A study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Patients with C3 Glomerulopathy or Immune-Complex Membranoprolifer… Ended

2023-504625-39-00 C3 glomerulopathy (C3G) or immune complex membranoproli 5 2023-05-18
OCEAN(a)-Outcomes – Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction – Outcomes trial Ended

2022-501608-85-00 Cardiovascular disease (atherosclerotic cardiovascular 5 2023-05-09
A research study looking at long-term treatment with Mim8 in people with haemophilia A (FRONTIER 4) Ended

2022-502215-10-00 Haemophilia A (with or without inhibitors) 5 2023-05-04
An Open-Label, Long Term Safety and Efficacy Study of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE) Ended

2023-509201-77-00 Hereditary Angioedema 5 2022-11-02
A research study to see how well CagriSema helps people with excess body weight lose weight Ended

2023-506929-11-00 Overweight and obesity 5 2022-10-17
A Placebo-Controlled Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With Atherosclerotic Cardiovascular Disease … Ended

2023-507795-51-00 atherosclerotic heart and blood vessel disease (the nar 5 2022-05-17
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease … Ended

2023-506926-35-00 Atherosclerotic cardiovascular disease, chronic kidney 5 2021-09-24
Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION373 in Patients with Alexande… Ended

2024-510603-11-00 Alexander Disease 7 2021-04-08
Research study on whether semaglutide works in people with non-alcoholic steatohepatitis (NASH) Ended

2023-506962-30-00 Non-alcoholic steatohepatitis (NASH) 5 2021-03-29
A phase 3 multicentre, randomized, prospective, open-label trial of Ibrutinib monotherapy versus fixed-duration Venetoclax plus Obinutuzumab… Ended

2022-500439-35-00 treatment-naive chronic lymphocytic leukemia 5 2021-02-11